Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP

NCT01915953 is registered in ClinicalTrials.gov with OrSense, Ltd. as lead sponsor.

NCT NCT01915953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01915953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Evaluation of the OrSense Non-invasive Blood Hb/Hct Measurement Instrument, the Hemo-Monitor NBM200/MP
Lead sponsor
OrSense, Ltd.
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2011
Completion date
December 31, 2013
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia